PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NOV.DE vs. QCOM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


NOV.DEQCOM
YTD Return37.28%18.04%
1Y Return49.18%55.18%
3Y Return (Ann)53.42%10.43%
5Y Return (Ann)54.72%19.85%
10Y Return (Ann)44.07%11.57%
Sharpe Ratio1.571.44
Daily Std Dev31.58%36.46%
Max Drawdown-87.90%-86.76%
Current Drawdown-11.70%-25.51%

Fundamentals


NOV.DEQCOM
Market Cap€528.87B$187.49B
EPS€2.69$7.83
PE Ratio44.1121.49
PEG Ratio2.031.21
Total Revenue (TTM)€93.49B$37.35B
Gross Profit (TTM)€79.25B$20.88B
EBITDA (TTM)€48.38B$10.92B

Correlation

-0.50.00.51.00.1

The correlation between NOV.DE and QCOM is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

NOV.DE vs. QCOM - Performance Comparison

In the year-to-date period, NOV.DE achieves a 37.28% return, which is significantly higher than QCOM's 18.04% return. Over the past 10 years, NOV.DE has outperformed QCOM with an annualized return of 44.07%, while QCOM has yielded a comparatively lower 11.57% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%AprilMayJuneJulyAugustSeptember
8.74%
1.31%
NOV.DE
QCOM

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NOV.DE vs. QCOM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOV.DE) and QUALCOMM Incorporated (QCOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NOV.DE
Sharpe ratio
The chart of Sharpe ratio for NOV.DE, currently valued at 1.83, compared to the broader market-4.00-2.000.002.001.83
Sortino ratio
The chart of Sortino ratio for NOV.DE, currently valued at 2.63, compared to the broader market-6.00-4.00-2.000.002.004.002.63
Omega ratio
The chart of Omega ratio for NOV.DE, currently valued at 1.32, compared to the broader market0.501.001.502.001.32
Calmar ratio
The chart of Calmar ratio for NOV.DE, currently valued at 3.05, compared to the broader market0.001.002.003.004.005.003.05
Martin ratio
The chart of Martin ratio for NOV.DE, currently valued at 11.35, compared to the broader market-10.00-5.000.005.0010.0015.0020.0011.35
QCOM
Sharpe ratio
The chart of Sharpe ratio for QCOM, currently valued at 1.58, compared to the broader market-4.00-2.000.002.001.58
Sortino ratio
The chart of Sortino ratio for QCOM, currently valued at 2.07, compared to the broader market-6.00-4.00-2.000.002.004.002.07
Omega ratio
The chart of Omega ratio for QCOM, currently valued at 1.29, compared to the broader market0.501.001.502.001.29
Calmar ratio
The chart of Calmar ratio for QCOM, currently valued at 1.36, compared to the broader market0.001.002.003.004.005.001.36
Martin ratio
The chart of Martin ratio for QCOM, currently valued at 5.05, compared to the broader market-10.00-5.000.005.0010.0015.0020.005.05

NOV.DE vs. QCOM - Sharpe Ratio Comparison

The current NOV.DE Sharpe Ratio is 1.57, which roughly equals the QCOM Sharpe Ratio of 1.44. The chart below compares the 12-month rolling Sharpe Ratio of NOV.DE and QCOM.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00AprilMayJuneJulyAugustSeptember
1.83
1.58
NOV.DE
QCOM

Dividends

NOV.DE vs. QCOM - Dividend Comparison

NOV.DE's dividend yield for the trailing twelve months is around 1.12%, less than QCOM's 1.96% yield.


TTM20232022202120202019201820172016201520142013
NOV.DE
Novo Nordisk A/S
1.12%1.01%1.18%1.27%1.99%2.09%5.96%2.28%3.69%1.25%1.69%1.82%
QCOM
QUALCOMM Incorporated
1.96%2.18%2.67%1.47%1.69%2.81%4.27%3.50%3.17%3.72%2.17%1.75%

Drawdowns

NOV.DE vs. QCOM - Drawdown Comparison

The maximum NOV.DE drawdown since its inception was -87.90%, roughly equal to the maximum QCOM drawdown of -86.76%. Use the drawdown chart below to compare losses from any high point for NOV.DE and QCOM. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AprilMayJuneJulyAugustSeptember
-8.35%
-25.51%
NOV.DE
QCOM

Volatility

NOV.DE vs. QCOM - Volatility Comparison

The current volatility for Novo Nordisk A/S (NOV.DE) is 6.66%, while QUALCOMM Incorporated (QCOM) has a volatility of 11.51%. This indicates that NOV.DE experiences smaller price fluctuations and is considered to be less risky than QCOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AprilMayJuneJulyAugustSeptember
6.66%
11.51%
NOV.DE
QCOM

Financials

NOV.DE vs. QCOM - Financials Comparison

This section allows you to compare key financial metrics between Novo Nordisk A/S and QUALCOMM Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Please note, different currencies. NOV.DE values in EUR, QCOM values in USD